Petrova Penka 4
4 · Trillium Therapeutics Inc. · Filed Apr 9, 2021
Insider Transaction Report
Form 4
Petrova Penka
Chief Development Officer
Transactions
- Exercise/Conversion
Common Shares
2021-04-08$3.36/sh+2,604$8,759→ 5,312 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-08−2,604→ 49,480 totalExercise: $3.36Exp: 2028-11-08→ Common Shares (2,604 underlying) - Exercise/Conversion
Common Shares
2021-04-08$0.30/sh+2,708$818→ 2,708 total - Sale
Common Shares
2021-04-08$11.09/sh−5,312$58,910→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-08−2,708→ 83,960 totalExercise: $0.30Exp: 2029-11-07→ Common Shares (2,708 underlying)
Footnotes (4)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7952 USD.
- [F3]The exercise price of these options is $4.23 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.7952 USD.
- [F4]25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.